Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹189.03
7.24 (3.98%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹330 Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
21.5
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹117.25+61.2%
52W High₹250-24.4%
Current Price
₹189.03
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹151.22
Upper Circuit₹226.84
Reference Price
₹189.03
Investment Checklist
Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹170.0
Inverse Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹208.68
Trend: Price above all key MAs — strong uptrend
Volume divergence: Bearish (price up, volume down)
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
77%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend
EMA20
176.1
EMA50
166.07
EMA200
173.08
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows5
Lower Highs5
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹191.85
₹197.00
₹203.00
₹206.02
₹211.82
Support (Below)
₹186.95
₹184.10
₹173.40
₹170.58
₹164.73
Volume Analysis
TrendDECREASING
Change-52.60%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹187.14
3% Risk₹183.36
5% Risk₹179.58
7% Risk (Custom)
₹175.80Technical Levels
1x ATR (Volatility)₹177.92
2x ATR (Swing)₹166.81
3x ATR (Trend)₹155.70
Immediate Support₹186.95
Moving Averages
EMA 9 (Short-term)₹181.12
EMA 20 (Medium-term)₹176.10
EMA 50 (Trend)₹166.07
EMA 200 (Long-term)₹173.08
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Sep '25 |
|---|---|---|---|---|
| Revenue | ₹56.2 Cr | ₹60.1 Cr | ₹43.1 Cr | ₹48.9 Cr |
| Net Profit | ₹6 Cr | ₹10.8 Cr | ₹3 Cr | ₹8.2 Cr |
| EPS | ₹3.63 | — | ₹1.84 | ₹4.97 |
| Operating Profit | ₹10.5 Cr | ₹16.7 Cr | ₹5.8 Cr | ₹11.7 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 24 Mar 2026 | Bonus 1:1 | BONUS |
| 15 Jul 2025 | Rights 2:23 @ Premium Rs 347/- | RIGHTS_ISSUE |
| 19 Sept 2024 | Annual General Meeting | AGM |
| 21 Sept 2023 | Annual General Meeting | AGM |
| 20 Sept 2022 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
| Date | Purpose | Links |
|---|---|---|
| 15 May 2026 | Board Meeting Intimation | |
| 15 May 2026 | Financial Results | |
| 11 Feb 2026 | Bonus | |
| 11 Feb 2026 | Other business matters | |
| 11 Feb 2026 | Financial Results |
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for KILITCH
View All
neutral
Google News - India Markets 37d ago
Kilitch Drugs (India) Ltd. Schedules Board Meeting on May 15, 2026 to Approve Q4FY26 Financial Results - scanx.trade
Kilitch Drugs (India) Ltd. Schedules Board Meeting on May 15, 2026 to Approve Q4FY26 Financial Resultsscanx.trade
JMFINANCILKILITCHFinancial ServicesHealthcare